Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Tara Ravi
2027 OPPS Final Rule: Implications for Outpatient Growth and Healthcare Transactions
On November 4, 2026, the Centers for Medicare & Medicaid Services (CMS) released its 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule. Most provisions take effect January 1, 2027. Beyond the annual payment updates, the rule has implications for outpatient expansion, physician partnerships, acquisitions and capital investments.
2027 OPPS Final Rule: Implications for Outpatient Growth and Healthcare Transactions
On November 4, 2026, the Centers for Medicare & Medicaid Services (CMS) released its 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) final rule. Most provisions take effect January 1, 2027. Beyond the annual payment updates, the rule has implications for outpatient expansion, physician partnerships, acquisitions and capital investments.
2027 OPPS: The 5 Provisions Health Systems Should Be Evaluating | JD Supra
CMS published its 2027 Outpatient Prospective Payment System proposed rule last month. At a moment when health systems across the country are signing letters of intent, closing acquisitions and negotiating capital commitments, this rule introduces five provisions that will reshape the financial math behind those decisions. Comments are due August 31. 1. The 340B drug payment cut is back, and it is bigger than before.
Takeaways from CMS' 2027 Outpatient Prospective Payment System Pr
CMS published its 2027 Outpatient Prospective Payment System proposed rule last month. Most health systems are treating it as a routine reimbursement update. It deserves more attention than that. At a moment when health systems across the country are signing letters of intent, closing acquisitions, and negotiating capital commitments, this rule introduces five provisions that will reshape the financial math behind those decisions. Comments are due August 31.
2027 OPPS: The 5 Provisions Health Systems Should Be Evaluating
Healthcare Alert CMS published its 2027 Outpatient Prospective Payment System proposed rule last month. At a moment when health systems across the country are signing letters of intent, closing acquisitions and negotiating capital commitments, this rule introduces five provisions that will reshape the financial math behind those decisions. Comments are due August 31. When the Supreme Court struck down CMS's earlier 340B payment reduction in American Hospital Association v.
Health Care Fraud and Abuse Laws: Georgia | JD Supra
March 5, 2026 To embed, copy and paste the code into your website or blog: A Q&A guide to health care-related fraud and abuse laws in Georgia. This Q&A addresses civil and criminal actions, consequences for violation, and Medicaid program integrity provisions. Originally Published by Thomson Reuters Practical Law - February 7, 2026. Please see full publication below for more information.
CMS Tests Prior Authorization for Ambulatory Surgery Centers: Preparing for the 2025 Demonstration | JD Supra
Overview CMS is launching a five-year Prior Authorization Demonstration for certain ambulatory surgical center (ASC) services beginning December 15, 2025, in 10 states, including Georgia, Florida, Tennessee, and Texas. The model will require ASCs to obtain prior authorization before performing selected procedures that CMS views as high-growth or medically variable — such as blepharoplasty, botulinum toxin injections, panniculectomy, rhinoplasty, and vein ablation.
CMS Launches Prior Authorization Demonstration for ASC Services
CMS is launching a five-year Prior Authorization Demonstration for certain ambulatory surgical center (ASC) services beginning December 15, 2025, in 10 states, including Georgia, Florida, and Tennessee. The model will require ASCs to obtain prior authorization before performing selected procedures that CMS views as high-growth or medically variable — such as blepharoplasty, botulinum toxin injections, panniculectomy, rhinoplasty, and vein ablation.
Women Investing in Women's Health: The Rise of Femtech Companies and Investors in Celebration of Women's History Month | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Women Investing in Women's Health: The Rise of Femtech Companies and Investors in Celebration of Women's History Month
Just a few years ago, investment in women’s health was sparse. Global funding for the femtech sector had barely reached $100 million and there continued to be a glaring lack of research into critical areas such as female heart disease and gynecological disorders. That is finally changing, driven in large part by female funders who have identified the value in the sector and have started putting their money to work.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Tara
Contact Tara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack